Comparing effect in the management of erectile dysfunction by using 2 sets of drugs of intracavernosal injection
Jian, H.-Y.; Hao, J.-C.
Zhonghua Nan Ke Xue 9(3): 200-201
2003
ISSN/ISBN: 1009-3591 PMID: 12861835 Document Number: 562395
To supply clinical data for drug selextion in the treatment of erectile dysfunction through intracavernosal injection. Fifty-six ED patients were randomly classified into 2 groups and received phentolamine along with papaverine (for group 1) or phentolamine, papaverine and ligustrazin hydrochloride(for group 2). Patients in group 2 enjoyed a longer time of erection. More patients in group 2 succeeded in having enough erection time and hardness to complete sexual intercourse (P < 0.05). The extrainjection of ligustrazin hydrochloride injection can help prolong erection duration and hardness and reduce tubercles that might occur in the corpus carvernosal. Therefore it is a safe and inexpensive drug in the intracarvernous injection treatment.